Modulation of inflammation by protease products
CA 2316405 A1 · Owner: Gong, Jiang-Hong · Inventors: Mcquibban, G. Angus; Overall, Christopher Mark; Clark-Lewis, Ian
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides methods of inhibiting the biological activity or the in vivo biological activity of CC-chemokines (including native MCP-3) such as, methods of inhibiting inflammation comprising administering to a host an, effective amount of a CC-chemokine receptor antagonist of the present invention. In same embodiments, the invention may provide methods of modulating an immune response in a host, or treating inflammation or autoimmune disease in a host suffering from such diseases, comprising administering to the host an effective amount of a CC-chemokine receptor antagonist of the present invention. Another aspect of the present invention is directed to pharmaceutical …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 18, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 18, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 18, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.